Could fewer biopsies be needed after a heart transplant? NYU combines ECG AI with blood markers to assess rejection
A small test suggests that integrating ECGs and blood biomarkers could reduce false alarms in rejection monitoring. But whether biopsies can safely be avoided still depends on confirming that the model does not miss patients who need treatment.